Clinical Trial Update: Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

This clinical trial update reports the termination of a Phase 4 study evaluating safinamide's effect on sleep quality in patients with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Safinamide (Safinamide)

Snippet

Sponsor: Alain Kaelin | Conditions: Idiopathic Parkinson's Disease (at Later Stage) | Phase 4 | Status: TERMINATED